Advertisement.

HSDT Projected Dividend Yield

Com Cl A 2023 (New)/Helius Medical Technologies Inc ( NASDAQ : HSDT )

Helius Medical Technologies, Inc. is a neurotech company focused on addressing neurologic deficits with its orally applied technology platform, which enhances the brain's compensatory mechanisms. Co. develops, licenses, or acquires non-implantable technologies aimed at reducing symptoms of neurological diseases or trauma. Its key product, the Portable Neuromodulation Stimulator (PoNS), is a non-implantable device that delivers mild electrical stimulation to the tongue, aiding in the treatment of gait and chronic balance deficits. PoNS Therapy, used alongside supervised therapeutic exercises, is prescribed for patients aged 22 and over.

20 YEAR PERFORMANCE RESULTS

HSDT Dividend History Detail
HSDT Dividend News
HSDT Competitors News

# of Shares: 0

Closing Price: 0.49

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000